A Phase II Study of Preoperative Systemic Chemotherapy (Modified FOLFIRINOX) Followed by Radiation Therapy for Patients With High Risk Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Fluorouracil (Primary) ; Gemcitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 19 Mar 2018 Planned End Date changed from 1 Jun 2019 to 1 Jun 2021.
- 19 Mar 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.
- 24 May 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.